Breaks Categories: News

ThursdayMar 09, 2017 2:23 pm

NetworkNewsBreaks – The Singing Machine Company, Inc. (SMDM) Enters Distribution Agreement with Alliance Entertainment

The Singing Machine Company, Inc. (OTCQX: SMDM), the North American leader in consumer karaoke products and a member of the 2017 OTCQX® Best 50, this morning announced its entry into a new distribution partnership agreement with Alliance Entertainment, a leading wholesale distributor of music, movies and consumer electronics servicing more than 2,000 independent music and video retailers. Through the new agreement, Alliance Entertainment will distribute SMDM’s Singing Machine and Singing Machine Kids product lines throughout its expansive retail distribution network, both domestically and internationally. “We are thrilled to be partnering with Alliance Entertainment to help us expand our reach into…

Continue Reading

ThursdayMar 09, 2017 11:16 am

NetworkNewsBreaks – Histogenics Corp. (NASDAQ: HSGX) Announces Publication of Data from Human Engineered Cartilage Testing; Shares Rise

Histogenics (NASDAQ: HSGX) this morning announced the online publication of biomechanical and structural data that analyzes mechanical properties of tissue engineered cartilage based on work done as part of a sponsored research agreement between Histogenics and Dr. Lawrence Bonassar at Cornell University. This was the first study to use three mechanical tests to examine and understand the performance of repaired cartilage in accordance with FDA guidance. Data from the study demonstrate Histogenics’ tissue engineered cartilage constructs exhibit mechanical properties approaching native human cartilage as early as three weeks in culture and prior to implantation. “The data generated in this study…

Continue Reading

ThursdayMar 09, 2017 11:14 am

NetworkNewsBreaks – Medigus Ltd. (NASDAQ: MDGS) Shares Rally on First MUSE Procedure in China

Shares of Medigus (NASDAQ: MDGS) gained 25% pre-market, currently up 9%, after the medical device company announced the completion of the first MUSE procedure in China. The procedure was performed by Professor Rong Wan, Department of Gastroenterology, Shanghai First People's Hospital, School of Medicine, Shanghai Jiao Tong University. Professor Wan reported that the procedure was successful with the patient encountering minimal discomfort. The MUSE system is a single-use flexible transoral stapler that enables a single physician to perform an incisionless transoral fundoplication, the procedure intended to treat the anatomical cause of gastroesophageal reflux disease (GERD). "With the completion of our…

Continue Reading

TuesdayMar 07, 2017 12:22 pm

NetworkNewsBreaks – ProBility Media Corp. (PBYA) Teams with GlobalSim to Launch VR Construction Crane Simulator

Education technology company ProBility Media Corp. (OTCQB: PBYA) this morning announced that it has teamed up with GlobalSim, Inc., a leading provider of simulators and training systems for a variety of industries, to introduce a virtual reality training simulator targeting the crane industry. The two companies have executed an exclusive agreement through which GlobalSim will provide the portable VR Construction Crane hardware and the eLearning software, while ProBility will commercialize the product through its extensive sales channels in both the United States and Canada. “Providing high quality training to the $35 billion crane industry is paramount in our strategy of…

Continue Reading

TuesdayMar 07, 2017 11:25 am

NetworkNewsBreaks – Aeterna Zentaris, Inc. (NASDAQ: AEZS) Receives EMA Pediatric Committee Agreement on PIP for Macrilen™

Shares of Aeterna Zentaris (NASDAQ: AEZS) are 6% higher in morning trade after the company said the European Medicines Agency’s (EMA) Pediatric Committee (PDCO) has agreed to the company’s Pediatric Investigation Plan (PIP) for Macrilen™. PDCO also agreed that Aeterna may defer conducting the PIP until after it files a Marketing Authorization Application (MAA) for the use of Macrilen™ for the evaluation of adult growth hormone deficiency. “PDCO’s agreement that we may defer conducting our PIP, allowing us to go forward with an MAA in adults prior to initiating of the pediatric development program, is an important step forward in…

Continue Reading

TuesdayMar 07, 2017 10:14 am

NetworkNewsBreaks – Net Element’s (NASDAQ: NETE) PayOnline Providing Single-Click Payment Services for RUNET-ID

Global payment technology provider Net Element, Inc. (NASDAQ: NETE) this morning announced that RUNET-ID, Russia’s largest Internet resource dedicated to the domestic IT industry and telecommunication events, has chosen PayOnline for its secure, single-click payment acceptance services. PayOnline will simplify the payment process for RUNET-ID’s user base of more than 500,000 IT professionals, enabling access to single-click transactions following a one-time entry of payment details. Per this morning’s update, this convenient transaction capability simplifies the payment process without compromising security. “We are honored to be recognized as the best payment partner for Russia's largest Internet resource with access to over…

Continue Reading

TuesdayMar 07, 2017 9:39 am

NetworkNewsBreaks – ORHub, Inc. (ORHB) CEO Featured in Audio Interview with NetworkNewsWire

Multifaceted financial news and publishing company NetworkNewsWire this morning announced the online availability of a new audio interview with ORHub, Inc. (OTC: ORHB) CEO Colt Melby. In the interview, Melby discusses ORHub’s operations, particularly as they relate to the company’s cloud-based health care software-as-a-service platform, which aims to decrease medical costs while improving outcomes in surgical care. Melby notes that ORHub’s innovative software platform “empowers care providers at every level of the surgical process to collaborate, organize, deliver, measure and reimburse in one intuitive, easy-to-use program.” The software is currently implemented in two major hospitals in California. Before wrapping up…

Continue Reading

MondayMar 06, 2017 11:37 am

NetworkNewsBreaks – DryShips, Inc. (NASDAQ: DRYS) Exercises Second Option to Purchase Very Large Gas Carrier for $83.5M

DryShips (NASDAQ: DRYS) said it has exercised its second option under a previously announced option agreement with Hyundai Heavy Industries Co., Ltd. (HHI) to acquire up to four Very Large Gas Carriers (VLGCs) for $83.5 million. Approximately 25% of the purchase price will be paid on closing, expected within March 2017. The remaining balance will be paid in installments until the vessel's delivery, which is currently under construction at HHI. The VLGC will be employed on a fixed rate time charter with five years firm duration to an oil major, and the charterer has options to extend the firm employment…

Continue Reading

MondayMar 06, 2017 10:06 am

NetworkNewsBreaks – Galectin Therapeutics (NASDAQ: GALT) Shares Hike on Positive Data from Phase 2a Clinical Trial of GR-MD-02

Shares of Galectin Therapeutics (NASDAQ: GALT) are up more than 8% this morning on the company’s report of positive results from an exploratory, phase 2a clinical trial with GR-MD-02 in patients with moderate-to-severe plaque psoriasis. The research, which was done in partnership with San Antonio Military Medical Center, shows that GR-MD-02 achieved an average PASI (Psoriasis Area and Severity Index) reduction of over 50% in all patients that participated in the 24-week trial. The data also showed no serious adverse events, further demonstrating the safety and efficacy of this novel investigational drug in this patient population. The company will be…

Continue Reading

FridayMar 03, 2017 11:21 am

NetworkNewsBreaks – NEMUS Bioscience, Inc. (NMUS), Catalent to Advance Development of NB1222 Human Dosage Formulation

NEMUS Bioscience (OTCQB: NMUS) this morning said it is moving forward with Catalent Pharma Solutions to advance development of a human-dosage suppository formulation of NB1222. NB1222 is the proprietary prodrug of tetrahydrocannabinol (THC) being developed for the treatment and management of chemotherapy-induced nausea and vomiting (CINV). NB1222, also known as the prodrug THC-valine-hemisuccinate, is synthetically manufactured and is not plant-derived. "The global CINV market is a multi-billion dollar opportunity with projected growth as populations live longer, increasing the likelihood of developing a malignancy over time," Nemus CEO and chief medical officer Brian Murphy, M.D. stated in the news release. To…

Continue Reading